Sort
11,323 grants matching “glioblastoma”
Therapeutics Studies of Primary CNS Malignancies
$142,136Patrick Y Wen · Dana-Farber Cancer Inst · U01 · FY2008 · CA
Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma
$142,007Aram Sandaldjian Modrek · University Of Southern California · K08 · FY2024 · CA
Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma
$142,007Aram Sandaldjian Modrek · University Of Southern California · K08 · FY2025 · CA
Outreach Core
$141,951Pamela Rose Jackson · Mayo Clinic Arizona · U54 · FY2023 · CA
Biostatistics and Bioinformatics Core
$141,830James E Herndon · Duke University · P50 · FY2021 · CA
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
$141,793Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2021 · CA
Rapid Electrical Impedance Spectroscopy for Detection of High-Frequency Irreversible Electroporation Ablation Growth in a Rodent Glioma Model
$141,793Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2021 · CA
Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma
$141,667Aram Sandaldjian Modrek · New York University School Of Medicine · K08 · FY2022 · CA
Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastoma
$141,667Aram Sandaldjian Modrek · University Of Southern California · K08 · FY2023 · CA
EXAMINATION OF UNDEFINED MOLECULAR ALTERATIONS IN GLIOMAS
$141,510University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
PROTEASES IN BRIAN TUMORS PROGNOSTIC SIGNIFICANCE
$141,510University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
MOLECULAR AND GENETIC EPIDEMIOLOGY OF GLIOMAS
$141,510University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
CORE--CLINICAL TRIALS
$141,510University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
Computational Modeling Core
$141,425Douglas A Lauffenburger · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Novel Mouse Models to Understand ST6Gal1-Mediated Sialylation Effects in the Developing and Pathologic Brain
$141,129Anita Borton Hjelmeland · University Of Alabama At Birmingham · R03 · FY2021 · NS
Targeting Acid Ceramidase to Improve the Efficacy of Herpes Oncolytic Virus
$141,129Anita Borton Hjelmeland · University Of Alabama At Birmingham · R03 · FY2022 · NS
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ
$141,075Timothy Cloughesy · University Of California Los Angeles · M01 · FY2010 · RR
Role of Olig Genes in Human Gliomagenesis
$140,940Santosh Kesari · University Of California, San Diego · K08 · FY2010 · CA
Role of Olig Genes in Human Gliomagenesis
$140,940Santosh Kesari · Dana-Farber Cancer Inst · K08 · FY2008 · CA
Role of Olig Genes in Human Gliomagenesis
$140,940Santosh Kesari · University Of California, San Diego · K08 · FY2011 · CA
Cellular Proliferation is a Robust Pharmacodynamic Endpoint
$140,604Alexander M Spence · University Of Washington · P01 · FY2013 · CA
Malignant Gliomas Biorepository Core
$140,569Ichiro Nakano · Ohio State University · P01 · FY2016 · CA
Role of Olig Genes in Human Gliomagenesis
$140,535Santosh Kesari · Dana-Farber Cancer Inst · K08 · FY2007 · CA
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods
$140,454Sriram Venneti · University Of Michigan At Ann Arbor · K08 · FY2015 · CA
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods
$140,454Sriram Venneti · University Of Michigan At Ann Arbor · K08 · FY2017 · CA